Legal Representation
Attorney
Enshan Hong
USPTO Deadlines
Next Deadline
1282 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-01-24)
Due Date
January 24, 2029
Grace Period Ends
July 24, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
17 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jan 24, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Jan 24, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Nov 8, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Nov 8, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Oct 19, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Oct 5, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Oct 5, 2022 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
Oct 5, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Oct 5, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Oct 5, 2022 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Oct 4, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Sep 1, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Sep 1, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Sep 1, 2022 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
Sep 1, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jan 5, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jan 4, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 044
Medical services; Medical consulting services in the field of disease infection control; Providing medical care services and consultation related thereto; Pharmaceutical and medical consultancy; Providing healthcare information and advisory services in the healthcare field; Medical consultation services featuring preparation of reports relating to medical and pharmaceutical services; Medical services, namely, providing therapies for treating proliferating diseases, cancers, infectious diseases, autoimmune diseases, metabolic diseases and neurodegenerative disease; Medical services, namely, providing therapeutic and prophylactic treatment of proliferating diseases, cancers, infectious diseases, autoimmune diseases, metabolic diseases, and neurodegenerative disease; Medical and pharmaceutical consultation; Medical diagnostic testing, monitoring and reporting services; Genetic testing for medical purposes
First Use Anywhere:
May 10, 2021
First Use in Commerce:
May 10, 2021
Additional Information
Design Mark
The mark consists of a stylized letter "R" sharing a stroke "|" with a stylized upside-down inverted "R", where the stylized letter "R" has two openings between the stroke "|" and the right part of "R" and the stylized upside-down inverted "R" has two openings between the stroke "|" and the left part of the upside-down inverted "R".
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
REVIR
Pseudo Mark
RR
Pseudo Mark
R R
Classification
International Classes
044